BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30240398)

  • 1. Survival prediction among patients with non-cancer-related end-stage liver disease.
    Tsai YW; Tzeng IS; Chen YC; Hsieh TH; Chang SS
    PLoS One; 2018; 13(9):e0202692. PubMed ID: 30240398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma.
    Hong YF; Chen ZH; Ma XK; Li X; Wu DH; Chen J; Dong M; Wei L; Wang TT; Ruan DY; Lin ZX; Wen JY; Lin Q; Jia CC; Wu XY
    Tumour Biol; 2016 Apr; 37(4):5265-73. PubMed ID: 26561464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].
    Zhou Q; Tan D; Yi Z; Zheng Y; Lu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Chen W; You J; Chen J; Zheng Q; Jiang JJ; Zhu YY
    World J Gastroenterol; 2017 Oct; 23(40):7303-7309. PubMed ID: 29142477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?
    Finkenstedt A; Dorn L; Edlinger M; Prokop W; Risch L; Griesmacher A; Graziadei I; Vogel W; Zoller H
    Liver Int; 2012 Sep; 32(8):1211-6. PubMed ID: 22380485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Hammad A; Okajima H; Uemoto S
    Transplantation; 2016 Nov; 100(11):2416-2423. PubMed ID: 27495765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease.
    Zhang M; Yin F; Chen B; Li Y; Yan L; Wen T; Li B
    Scand J Gastroenterol; 2012 Jul; 47(7):842-52. PubMed ID: 22546008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for end-stage liver disease-sodium and survival benefit in liver transplantation.
    Vitale A; Bertacco A; Gambato M; D'Amico F; Morales RR; Frigo AC; Zanus G; Burra P; Angeli P; Cillo U
    Transpl Int; 2013 Feb; 26(2):138-44. PubMed ID: 23194386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure.
    Chen RC; Wang XD; Dong JZ; Lin Z; Wu JM; Cai YJ; Shi KQ
    Clin Chim Acta; 2017 May; 468():195-200. PubMed ID: 28283440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the model for end-stage liver disease score for guiding clinical decision-making in the selection of patients for emergency cardiac transplantation.
    Vanhuyse F; Maureira P; Mattei MF; Laurent N; Folliguet T; Villemot JP
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):134-8. PubMed ID: 23345182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.